GENERIC NAME: Ranitidine BRAND NAME: Zantac CLASSIFICATION Therapeutic: Anti-Ulcer Agents
GENERIC NAME: Ranitidine BRAND NAME: Zantac CLASSIFICATION Therapeutic: Anti-Ulcer Agents
GENERIC NAME: Ranitidine BRAND NAME: Zantac CLASSIFICATION Therapeutic: Anti-Ulcer Agents
CLASSIFICATION
Therapeutic:
Anti-ulcer agents
MECHANISM OF ACTION
• Inhibits the action of histamine at the H2 receptor site
located primarily in gastric parietal cells, resulting in
inhibition of gastric acid secretion.
INDICATION
•Treatment and prevention of heartburn, acid indigestion,
and sour stomach.
CONTRA INDICATIONS
Contraindicated in:
• CV:
Arrhythmias
• GI:
Altered taste, black tongue, constipation, dark stools,
diarrhea, drug-induced hepatitis, nausea
• GU:
Decreased sperm count, impotence
• ENDO:
Gynecomastia
• HEMAT:
Agranulocytosis, Aplastic Anemia, neutropenia,
thrombocytopenia
• LOCAL:
Pain at IM site
• MISC:
Hypersensitivity reactions, vasculitis
Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins
(PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in
bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to
ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell
wall assembly is arrested.
Contraindications:
iNDICATION :
· Both cefuroxime sodium and cefuroxime axetil is used in treating infections of Upper and
Lower respiratory tract, skin and soft tissue, UTI, bone & joint infections and gonococcal
infections.
ADVERSE REACTIONS :
Adverse Reactions
GI
Nausea; vomiting; diarrhea; anorexia; abdominal pain or cramps; flatulence; colitis, including
pseudomembranous colitis.
Genitourinary
Pyuria; renal dysfunction; dysuria; reversible interstitial nephritis; hematuria; toxic nephropathy.
Hematologic
Hepatic
Miscellaneous